Trial intelligence / Profile preview

Effects of inhaled THC on resting-state fMRI in healthy volunteers

NL-OMON20151Not yet recruiting

Sponsor
CHDR in cooperation with LUMC
Start
Jan 2009
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of dronabinol, sponsored by CHDR in cooperation with LUMC. Primary endpoints: Resting state network activity, Arterial spin labeling cerebral blood flow and 1 more. Planned start Jan 2009; status: not yet recruiting.

02

Drugs

dronabinol

Beyond the preview

Go deeper on NL-OMON20151.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON20151.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call